Article info
PDFCase study
Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases
- Correspondence to Dr Amit M Oza, Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, ON M5G 2C9, Canada; amit.oza{at}uhn.ca
Citation
Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases
Publication history
- Accepted August 24, 2020
- First published September 30, 2020.
Online issue publication
February 28, 2022
Article Versions
- Previous version (4 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.